Anticoagulation and Antiplatelet Agents in Peripheral Arterial Interventions
- PMID: 36406033
- PMCID: PMC9671689
- DOI: 10.1055/s-0042-1757314
Anticoagulation and Antiplatelet Agents in Peripheral Arterial Interventions
Abstract
Effective revascularization of peripheral artery disease relies on periprocedural pharmacological regulation of the clotting cascade. Patient-specific factors such as cardiovascular risk factors, contraindications, and individual psychosocial factors must be considered when initiating post revascularization management. Management with anticoagulant and antiplatelet agents is discussed to guide the interventionalist on which therapy may be appropriate for their patient. While exact treatment may be institution and provider dependent, the interventionist must be familiar with the available classes of medications and how they can be prescribed in the postprocedural setting to improve cardiovascular outcomes.
Keywords: anticoagulant; antiplatelet; dual-antiplatelet therapy; interventional radiology; peripheral artery disease.
Thieme. All rights reserved.
Conflict of interest statement
Conflict of Interest None declared.
Similar articles
-
The impact of pre-injury anticoagulation therapy in the older adult patient experiencing a traumatic brain injury: A systematic review.JBI Libr Syst Rev. 2012;10(58):4610-4621. doi: 10.11124/jbisrir-2012-429. JBI Libr Syst Rev. 2012. PMID: 27820526
-
A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.Circulation. 2017 Jun 20;135(25):2534-2555. doi: 10.1161/CIRCULATIONAHA.117.024469. Circulation. 2017. PMID: 28630267 Review.
-
Incidence of venous thromboembolism in patients with peripheral arterial disease after endovascular intervention.J Vasc Surg Venous Lymphat Disord. 2023 Jan;11(1):61-69. doi: 10.1016/j.jvsv.2022.08.009. Epub 2022 Sep 29. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36182086 Free PMC article.
-
Increased long-term bleeding complications in females undergoing endovascular revascularization for peripheral arterial disease.J Vasc Surg. 2022 Oct;76(4):1021-1029.e3. doi: 10.1016/j.jvs.2022.04.048. Epub 2022 Jun 11. J Vasc Surg. 2022. PMID: 35700858 Free PMC article.
-
The role of antiplatelet therapy in patients with peripheral artery disease and lower extremity peripheral artery revascularization.Curr Opin Cardiol. 2015 Sep;30(5):525-35. doi: 10.1097/HCO.0000000000000208. Curr Opin Cardiol. 2015. PMID: 26241710 Review.
References
-
- Lopez A D, Murray C CJL. The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241–1243. - PubMed
-
- Guez D, Hansberry D R, Gonsalves C F. Recent trends in endovascular and surgical treatment of peripheral arterial disease in the Medicare population. AJR Am J Roentgenol. 2020;214(05):962–966. - PubMed
-
- Davidson J C, Rahim S, Hanks S E. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part I: Review of anticoagulation agents and clinical considerations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol. 2019;30(08):1155–1167. - PubMed